224 related articles for article (PubMed ID: 27639619)
1. Asp32 and Asp228 determine the selective inhibition of BACE1 as shown by docking and molecular dynamics simulations.
Hernández-Rodríguez M; Correa-Basurto J; Gutiérrez A; Vitorica J; Rosales-Hernández MC
Eur J Med Chem; 2016 Nov; 124():1142-1154. PubMed ID: 27639619
[TBL] [Abstract][Full Text] [Related]
2. Molecular insights into the inhibitory mechanism of bi-functional bis-tryptoline triazole against β-secretase (BACE1) enzyme.
Narang SS; Goyal D; Goyal B
Amino Acids; 2019 Nov; 51(10-12):1593-1607. PubMed ID: 31654211
[TBL] [Abstract][Full Text] [Related]
3. Identification of new BACE1 inhibitors using Pharmacophore and Molecular dynamics simulations approach.
Dhanabalan AK; Kesherwani M; Velmurugan D; Gunasekaran K
J Mol Graph Model; 2017 Sep; 76():56-69. PubMed ID: 28710924
[TBL] [Abstract][Full Text] [Related]
4. A series of molecular modeling techniques to reveal selective mechanisms of inhibitors to β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) and β-site amyloid precursor protein cleaving enzyme 2 (BACE2).
Li S; Zhao H; Li J; Hao J; Yu H
J Biomol Struct Dyn; 2021 May; 39(8):2824-2837. PubMed ID: 32276567
[TBL] [Abstract][Full Text] [Related]
5. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
[TBL] [Abstract][Full Text] [Related]
6. N-(2-(Piperazin-1-yl)phenyl)arylamide Derivatives as β-Secretase (BACE1) Inhibitors: Simple Synthesis by Ugi Four-Component Reaction and Biological Evaluation.
Edraki N; Firuzi O; Fatahi Y; Mahdavi M; Asadi M; Emami S; Divsalar K; Miri R; Iraji A; Khoshneviszadeh M; Firoozpour L; Shafiee A; Foroumadi A
Arch Pharm (Weinheim); 2015 May; 348(5):330-7. PubMed ID: 25787800
[TBL] [Abstract][Full Text] [Related]
7. A comparative molecular dynamics study on BACE1 and BACE2 flap flexibility.
Kumalo HM; Soliman ME
J Recept Signal Transduct Res; 2016 Oct; 36(5):505-14. PubMed ID: 26804314
[TBL] [Abstract][Full Text] [Related]
8. Modeling the protonation states of β-secretase binding pocket by molecular dynamics simulations and docking studies.
Sabbah DA; Zhong HA
J Mol Graph Model; 2016 Jul; 68():206-215. PubMed ID: 27474865
[TBL] [Abstract][Full Text] [Related]
9. Screening and Elucidation of Selected Natural Compounds for Anti- Alzheimer's Potential Targeting BACE-1 Enzyme: A Case Computational Study.
Ahmad SS; Akhtar S; Danish Rizvi SM; Kamal MA; Sayeed U; Khan MKA; Siddiqui MH; Arif JM
Curr Comput Aided Drug Des; 2017 Nov; 13(4):311-318. PubMed ID: 28413992
[TBL] [Abstract][Full Text] [Related]
10. Conformational transition in the substrate binding domain of β-secretase exploited by NMA and its implication in inhibitor recognition: BACE1-myricetin a case study.
Chakraborty S; Kumar S; Basu S
Neurochem Int; 2011 Jul; 58(8):914-23. PubMed ID: 21354237
[TBL] [Abstract][Full Text] [Related]
11. Polymethoxyflavones: Novel β-Secretase (BACE1) Inhibitors from Citrus Peels.
Youn K; Yu Y; Lee J; Jeong WS; Ho CT; Jun M
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28869548
[TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanism of Binding Selectivity of Inhibitors toward BACE1 and BACE2 Revealed by Multiple Short Molecular Dynamics Simulations and Free-Energy Predictions.
Chen J; Wang J; Yin B; Pang L; Wang W; Zhu W
ACS Chem Neurosci; 2019 Oct; 10(10):4303-4318. PubMed ID: 31545898
[TBL] [Abstract][Full Text] [Related]
13. Acylguanidine-BACE1 complex: Insights of intermolecular interactions and dynamics.
Saravanan K; Kumaradhas P
J Theor Biol; 2019 Mar; 464():33-49. PubMed ID: 30571961
[TBL] [Abstract][Full Text] [Related]
14. Determination of the active site protonation state of beta-secretase from molecular dynamics simulation and docking experiment: implications for structure-based inhibitor design.
Park H; Lee S
J Am Chem Soc; 2003 Dec; 125(52):16416-22. PubMed ID: 14692784
[TBL] [Abstract][Full Text] [Related]
15. A PM7 dynamic residue-ligand interactions energy landscape of the BACE1 inhibitory pathway by hydroxyethylamine compounds. Part I: The flap closure process.
Gueto-Tettay C; Martinez-Consuegra A; Zuchniarz J; Gueto-Tettay LR; Drosos-Ramírez JC
J Mol Graph Model; 2017 Sep; 76():274-288. PubMed ID: 28746905
[TBL] [Abstract][Full Text] [Related]
16. Identification of BACE1 inhibitors from Panax ginseng saponins-An Insilco approach.
Karpagam V; Sathishkumar N; Sathiyamoorthy S; Rasappan P; Shila S; Kim YJ; Yang DC
Comput Biol Med; 2013 Sep; 43(8):1037-44. PubMed ID: 23816176
[TBL] [Abstract][Full Text] [Related]
17. Flexibility of the flap in the active site of BACE1 as revealed by crystal structures and molecular dynamics simulations.
Xu Y; Li MJ; Greenblatt H; Chen W; Paz A; Dym O; Peleg Y; Chen T; Shen X; He J; Jiang H; Silman I; Sussman JL
Acta Crystallogr D Biol Crystallogr; 2012 Jan; 68(Pt 1):13-25. PubMed ID: 22194329
[TBL] [Abstract][Full Text] [Related]
18. Investigation of intermolecular interactions and stability of verubecestat in the active site of BACE1: Development of first model from QM/MM-based charge density and MD analysis.
Saravanan K; Sivanandam M; Hunday G; Mathiyalagan L; Kumaradhas P
J Biomol Struct Dyn; 2019 Jun; 37(9):2339-2354. PubMed ID: 30044206
[TBL] [Abstract][Full Text] [Related]
19. Interaction mechanism exploration of HEA derivatives as BACE1 inhibitors by in silico analysis.
Wu Q; Li X; Gao Q; Wang J; Li Y; Yang L
Mol Biosyst; 2016 Apr; 12(4):1151-65. PubMed ID: 26915506
[TBL] [Abstract][Full Text] [Related]
20. Discovery of imidazopyridines containing isoindoline-1,3-dione framework as a new class of BACE1 inhibitors: Design, synthesis and SAR analysis.
Azimi S; Zonouzi A; Firuzi O; Iraji A; Saeedi M; Mahdavi M; Edraki N
Eur J Med Chem; 2017 Sep; 138():729-737. PubMed ID: 28728105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
